Leonard Aliff, the managing director of Duopharma Group, issued a statement that the latest move of the group is consistent with the national vaccination plan, which is to open up domestic vaccines for a long time and reduce dependence on other countries.
The director of health, Dr. Tan Sri Noshiyama, told the media that the National Pharmaceutical Regulatory Agency (NPRA) has not approved Satellite 5 and the vaccine is still under review. Latipov said that cooperation with Duopharma depends on Satellite 5's approval of the NPRA, and believes that the transaction will become a new "pushing force" for the future trade ties between Russia and Malaysia.
As more and more governments believe that Satellite 5 is safe, the number of orders for Satellite 5 worldwide is currently increasing exponentially.
India is one of the world's largest vaccine producers. The country signed a partnership with the Russian Investment and Development Fund in December last year and will produce 300 million doses of Satellite V this year.
Italy also signed the same partnership with the Russian Investment and Development Fund on March 9, becoming the first EU country to sign a related agreement.
Although EU regulatory agencies have not yet approved the vaccine, the public health agencies of Hungary, the Czech Republic, and Slovenia have announced that the vaccine is safe for public use.
Kuala Lumpur, 10th) Russia offers to share vaccine production skills and technologies with Malaysia to help my country become a vaccine producer and reduce dependence on other countries.
At present, Russia is the only country that proposes to produce vaccines in Malaysia, because Russia believes that Malaysia’s strategic geographical location is conducive to becoming a vaccine export base in the region. According to the Malay Mail, the Russian ambassador to Malaysia Latipov said that Russia offers to cooperate with Malaysia and is willing to share vaccine production skills and knowledge, capacity building, technology sharing, and vaccine research and development. The next pandemic is coming. If it strikes, Malaysia can make its own vaccine.
"As far as I know, it only takes two or three hours to get from Malaysia to any Southeast Asian country. That's why we think Malaysia is a good place to have this vaccine because it is easy to export the vaccine." Malaysia has ordered 6 million doses of Sputnik V coronavirus vaccine as part of its vaccine inventory, allowing 80% of the population to be vaccinated by the end of this year.
According to reports, except Singapore, all countries in the region are deeply interested in Satellite 5 The Russian ambassador to Malaysia Latipov said that Russia may be on the cusp of geopolitical change, thanks to the Satellite V, which allows the country to drive alongside other major technological powers.
He said that Satellite 5 was developed by the Gamaleya Institute in Moscow, which will work directly with local players, which will help build trust and speed up progress.
According to official sources in Russia, as of the end of February this year, more than 2 billion vaccine orders have been received. So far, 50 countries have approved their populations to be vaccinated with the Satellite V vaccine.
The Russian Investment and Development Fund is the only global sales agent of the vaccine, and it will oversee export matters. The fund cooperated with Duopharma Biotechnology Company to provide Satellite 5 for Malaysia.
Duopharma issued a statement in January this year, stating that the company signed an agreement with the Russian Investment and Development Fund to purchase and supply 6.4 million doses of Satellite 5 for the Ministry of Health.
The company has also been identified as a partner for local vaccine development capabilities. Its parent company Duopharma (M) Sdn Bhd (DMSB) said it will provide warehouses, logistics, ground support and other services to government hospitals and clinics.